vs

Side-by-side financial comparison of BARRICK MINING CORP (B) and Emerson Electric (EMR). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $3.7B, roughly 1.2× BARRICK MINING CORP). BARRICK MINING CORP runs the higher net margin — 34.1% vs 13.9%, a 20.2% gap on every dollar of revenue. On growth, BARRICK MINING CORP posted the faster year-over-year revenue change (16.4% vs 4.1%).

Barrick Mining Corporation is a mining company that produces gold and copper. It has mining operations and projects in Argentina, Canada, Chile, Democratic Republic of the Congo, Dominican Republic, Ecuador, Egypt, Jamaica, Mali, Pakistan, Papua New Guinea, Peru, Saudi Arabia, Senegal, Tanzania, the United States and Zambia. In 2024, it produced 3.91 million ounces of gold at all-in sustaining costs of $1,484/ounce and 195,000 tonnes of copper at all-in sustaining costs of $3.45/pound. As of ...

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

B vs EMR — Head-to-Head

Bigger by revenue
EMR
EMR
1.2× larger
EMR
$4.3B
$3.7B
B
Growing faster (revenue YoY)
B
B
+12.3% gap
B
16.4%
4.1%
EMR
Higher net margin
B
B
20.2% more per $
B
34.1%
13.9%
EMR

Income Statement — Q2 FY2025 vs Q1 FY2026

Metric
B
B
EMR
EMR
Revenue
$3.7B
$4.3B
Net Profit
$1.3B
$605.0M
Gross Margin
49.0%
53.2%
Operating Margin
38.5%
17.8%
Net Margin
34.1%
13.9%
Revenue YoY
16.4%
4.1%
Net Profit YoY
98.1%
3.4%
EPS (diluted)
$0.47
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
B
B
EMR
EMR
Q4 25
$4.3B
Q3 25
$4.9B
Q2 25
$3.7B
$4.6B
Q1 25
$4.4B
Q4 24
$4.2B
Q3 24
$4.6B
Q2 24
$3.2B
$4.4B
Q1 24
$4.4B
Net Profit
B
B
EMR
EMR
Q4 25
$605.0M
Q3 25
$637.0M
Q2 25
$1.3B
$586.0M
Q1 25
$485.0M
Q4 24
$585.0M
Q3 24
$996.0M
Q2 24
$634.0M
$329.0M
Q1 24
$501.0M
Gross Margin
B
B
EMR
EMR
Q4 25
53.2%
Q3 25
51.9%
Q2 25
49.0%
52.6%
Q1 25
53.5%
Q4 24
53.5%
Q3 24
51.3%
Q2 24
37.4%
52.8%
Q1 24
52.2%
Operating Margin
B
B
EMR
EMR
Q4 25
17.8%
Q3 25
16.4%
Q2 25
38.5%
16.1%
Q1 25
14.2%
Q4 24
18.6%
Q3 24
14.7%
Q2 24
34.5%
10.4%
Q1 24
16.2%
Net Margin
B
B
EMR
EMR
Q4 25
13.9%
Q3 25
13.1%
Q2 25
34.1%
12.9%
Q1 25
10.9%
Q4 24
14.0%
Q3 24
21.6%
Q2 24
20.1%
7.5%
Q1 24
11.4%
EPS (diluted)
B
B
EMR
EMR
Q4 25
$1.07
Q3 25
$1.12
Q2 25
$0.47
$1.04
Q1 25
$0.86
Q4 24
$1.02
Q3 24
$1.74
Q2 24
$0.21
$0.57
Q1 24
$0.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
B
B
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$4.8B
Total DebtLower is stronger
$7.6B
Stockholders' EquityBook value
$33.4B
$20.3B
Total Assets
$47.3B
$41.9B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
B
B
EMR
EMR
Q4 25
Q3 25
Q2 25
$4.8B
Q1 25
Q4 24
Q3 24
Q2 24
$4.0B
Q1 24
Total Debt
B
B
EMR
EMR
Q4 25
$7.6B
Q3 25
$8.9B
Q2 25
$8.3B
Q1 25
$8.2B
Q4 24
$6.6B
Q3 24
$7.7B
Q2 24
$7.1B
Q1 24
$7.6B
Stockholders' Equity
B
B
EMR
EMR
Q4 25
$20.3B
Q3 25
$20.3B
Q2 25
$33.4B
$19.9B
Q1 25
$19.2B
Q4 24
$20.5B
Q3 24
$21.6B
Q2 24
$32.5B
$20.8B
Q1 24
$20.9B
Total Assets
B
B
EMR
EMR
Q4 25
$41.9B
Q3 25
$42.0B
Q2 25
$47.3B
$42.5B
Q1 25
$42.0B
Q4 24
$42.6B
Q3 24
$44.2B
Q2 24
$46.2B
$45.6B
Q1 24
$46.4B
Debt / Equity
B
B
EMR
EMR
Q4 25
0.37×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
Q3 24
0.36×
Q2 24
0.34×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
B
B
EMR
EMR
Operating Cash FlowLast quarter
$1.3B
$699.0M
Free Cash FlowOCF − Capex
$602.0M
FCF MarginFCF / Revenue
13.9%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
1.06×
1.16×
TTM Free Cash FlowTrailing 4 quarters
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
B
B
EMR
EMR
Q4 25
$699.0M
Q3 25
$3.1B
Q2 25
$1.3B
$1.1B
Q1 25
$241.0M
Q4 24
$777.0M
Q3 24
$3.3B
Q2 24
$1.2B
$1.1B
Q1 24
$743.0M
Free Cash Flow
B
B
EMR
EMR
Q4 25
$602.0M
Q3 25
$2.7B
Q2 25
$977.0M
Q1 25
$154.0M
Q4 24
$694.0M
Q3 24
$2.9B
Q2 24
$998.0M
Q1 24
$661.0M
FCF Margin
B
B
EMR
EMR
Q4 25
13.9%
Q3 25
54.9%
Q2 25
21.5%
Q1 25
3.5%
Q4 24
16.6%
Q3 24
63.1%
Q2 24
22.8%
Q1 24
15.1%
Capex Intensity
B
B
EMR
EMR
Q4 25
2.2%
Q3 25
8.9%
Q2 25
2.0%
Q1 25
2.0%
Q4 24
2.0%
Q3 24
9.1%
Q2 24
2.1%
Q1 24
1.9%
Cash Conversion
B
B
EMR
EMR
Q4 25
1.16×
Q3 25
4.86×
Q2 25
1.06×
1.83×
Q1 25
0.50×
Q4 24
1.33×
Q3 24
3.35×
Q2 24
1.83×
3.31×
Q1 24
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

B
B

Segment breakdown not available.

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons